<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="correction" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Ann Intensive Care</journal-id><journal-id journal-id-type="iso-abbrev">Ann Intensive Care</journal-id><journal-title-group><journal-title>Annals of Intensive Care</journal-title></journal-title-group><issn pub-type="epub">2110-5820</issn><publisher><publisher-name>Springer International Publishing</publisher-name><publisher-loc>Cham</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39888514</article-id><article-id pub-id-type="pmc">PMC11785843</article-id>
<article-id pub-id-type="publisher-id">1403</article-id><article-id pub-id-type="doi">10.1186/s13613-024-01403-1</article-id><article-categories><subj-group subj-group-type="heading"><subject>Correction</subject></subj-group></article-categories><title-group><article-title>Correction: Fluid accumulation syndrome in&#x000a0;sepsis and&#x000a0;septic shock: pathophysiology, relevance and&#x000a0;treatment&#x02014;a comprehensive review</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0326-2770</contrib-id><name><surname>Pfortmueller</surname><given-names>Carmen Andrea</given-names></name><address><email>carmen.pfortmueller@insel.ch</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Dabrowski</surname><given-names>Wojciech</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Wise</surname><given-names>Rob</given-names></name><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>van Regenmortel</surname><given-names>Niels</given-names></name><xref ref-type="aff" rid="Aff6">6</xref><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>Malbrain</surname><given-names>Manu L. N. G.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff8">8</xref><xref ref-type="aff" rid="Aff9">9</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01q9sj412</institution-id><institution-id institution-id-type="GRID">grid.411656.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 0479 0855</institution-id><institution>Department of Intensive Care, Inselspital, </institution><institution>Bern University Hospital and University of Bern, </institution></institution-wrap>Freiburgstrasse 10, 3010 Bern, Switzerland </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/016f61126</institution-id><institution-id institution-id-type="GRID">grid.411484.c</institution-id><institution-id institution-id-type="ISNI">0000 0001 1033 7158</institution-id><institution>First Department of Anaesthesiology and Intensive Therapy, </institution><institution>Medical University of Lublin, </institution></institution-wrap>Lublin, Poland </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04qzfn040</institution-id><institution-id institution-id-type="GRID">grid.16463.36</institution-id><institution-id institution-id-type="ISNI">0000 0001 0723 4123</institution-id><institution>Department of Anaesthesia and Critical Care, School of Clinical Medicine, </institution><institution>University of KwaZulu-Natal, </institution></institution-wrap>Durban, South Africa </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/006e5kg04</institution-id><institution-id institution-id-type="GRID">grid.8767.e</institution-id><institution-id institution-id-type="ISNI">0000 0001 2290 8069</institution-id><institution>Faculty Medicine and Pharmacy, </institution><institution>Vrije Universiteit Brussel (VUB), </institution></institution-wrap>Brussels, Belgium </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0080acb59</institution-id><institution-id institution-id-type="GRID">grid.8348.7</institution-id><institution-id institution-id-type="ISNI">0000 0001 2306 7492</institution-id><institution>Intensive Care Department, </institution><institution>John Radcliffe Hospital, Oxford University Trust Hospitals, </institution></institution-wrap>Oxford, UK </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/008x57b05</institution-id><institution-id institution-id-type="GRID">grid.5284.b</institution-id><institution-id institution-id-type="ISNI">0000 0001 0790 3681</institution-id><institution>Department of Intensive Care Medicine, </institution><institution>Ziekenhuis Netwerk Antwerpen Campus Stuivenberg/Cadix, </institution></institution-wrap>Antwerp, Belgium </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01hwamj44</institution-id><institution-id institution-id-type="GRID">grid.411414.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 0626 3418</institution-id><institution>Department of Intensive Care Medicine, </institution><institution>Antwerp University Hospital, </institution></institution-wrap>Antwerp, Belgium </aff><aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="GRID">grid.513150.3</institution-id><institution>International Fluid Academy, </institution></institution-wrap>Lovenjoel, Belgium </aff><aff id="Aff9"><label>9</label>Medical Data Management, Medaman, Geel, Belgium </aff></contrib-group><pub-date pub-type="epub"><day>31</day><month>1</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>31</day><month>1</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>15</volume><elocation-id>21</elocation-id><permissions><copyright-statement>&#x000a9; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p></license></permissions><related-article related-article-type="corrected-article" ext-link-type="doi" xlink:href="10.1186/s13613-024-01336-9" id="d33e49"/><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; La Soci&#x000e9;t&#x000e9; de R&#x000e9;animation de Langue Francaise = The French Society of Intensive Care (SRLF) 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p id="Par1">
<bold>Correction: Annals of Intensive Care (2024) 14:115 </bold>
10.1186/s13613-024-01336-9
</p><p id="Par2">Following publication of the original article, the authors removed the word &#x0201c;prevention&#x0201d; in Table <xref rid="Tab1" ref-type="table">1</xref> as it is already in the table title and the title of Table <xref rid="Tab2" ref-type="table">2</xref> has been corrected. Table <xref rid="Tab3" ref-type="table">3</xref> has been edited. The corrected tables <xref rid="Tab1" ref-type="table">1</xref>, <xref rid="Tab2" ref-type="table">2</xref> and <xref rid="Tab3" ref-type="table">3</xref> are given below.<table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Prevention and monitoring of fluid accumulation syndrome (FAS)</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left">NOTE: Fluids should only be administrated when hypovolemia, fluid responsiveness AND signs of impaired tissue perfusion are present</td></tr><tr><td align="left"><p><italic>Monitoring</italic></p><p>&#x02013; Basic monitoring (i.e. arterial and central venous line),</p><p>&#x02013; in case of unresolved shock consider echocardiography and advanced hemodynamic monitoring (eg. pulse contour or transpulmonary thermodilution)</p><p>&#x02013; obtain baseline body weight (scale, estimate, retrieve from medical records)</p><p>&#x02013; Monitor for risk for fluid accumulation: i.e. daily body weight, daily and cumulative fluid balance, edema formation, sonography</p><p>&#x02013; Assess for impaired end-organ function: IAP, APP, PF ratio, success of EN, EVLWI, PVPI, BIA</p><p>&#x02013; Assess fluid responsiveness with functional hemodynamics (i.e. PPV or SVV, passive leg raising test, end-expiratory occlusion test)</p><p>&#x02013; Assess for signs of tissue hypoperfusion (DO<sub>2</sub>/VO<sub>2</sub> mismatch; i.e. elevated lactate, increased mottling score, increased capillary refill time)</p></td></tr><tr><td align="left"><p><italic>Prevention</italic></p><p>A) Fluids are required</p><p>&#x02013; use a restrictive fluid management regime</p><p>&#x02013; when maintenance fluids are necessary, opt for balanced and sodium-poor alternatives (NaCl 0.18&#x02013;0.45%)</p><p>&#x02013; Use low-chloride alternatives to NaCl 0.9% when selecting resuscitation and replacement fluids</p><p>&#x02013; frequently re-assess preload and fluid responsiveness/tissue perfusion, only administer fluids in fluid responsive patients</p><p>&#x02013; consider early norepinephrine use</p><p>&#x02013; <underline>stop</underline> fluid administration once fluid responsiveness and/or tissue perfusion are absent</p><p>&#x02013; consider the (early) use of albumin 20%, especially when serum albumin levels are low (&#x0003c;&#x02009;30g/L) [<xref ref-type="bibr" rid="CR1">1</xref>]</p><p>B) Fluids are not required: de-escalation</p><p>&#x02013; Limit fluid intake</p><p>&#x02013; Limit sodium intake</p><p>&#x02013; Limit/avoid maintenance solutions</p><p>&#x02013; Limit/avoid fluid creep</p><p>&#x02013; Improve lymphatic drainage (i.e. use leg compression bandages)</p><p>&#x02013; Use high density or concentrated enteral formula&#x02019;s (i.e. 2 kcal/ml)</p></td></tr></tbody></table><table-wrap-foot><p>Table adapted with permission from Malbrain et al. according to the Open Access CC BY Licence 4.0 (ESM file) [<xref ref-type="bibr" rid="CR2">2</xref>]</p><p>This table presents some suggestions for prevention of fluid accumulation based on personal experience of the co-authors. It does not aim to provide an exhaustive, graded and concise overview of the literature as current evidence is mostly limited to observational, retrospective or small clinical studies, and more randomized trials are needed to better establish a personalized approach to fluid management. For more information we refer the reader to some recent review papers on this topic [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]</p><p><italic>EN</italic>: enteral nutrition, <italic>EVLWI</italic>: extra-vascular lung water index, <italic>FA</italic>: fluid accumulation, <italic>APP</italic>: abdominal perfusion pressure (MAP minus IAP), <italic>IAP</italic>: intra-abdominal pressure, <italic>PEEP</italic>: positive end-expiratory pressure, <italic>PF</italic>: P<sub>a</sub>O<sub>2</sub> over F<sub>i</sub>O<sub>2</sub> ratio, <italic>PPV</italic>: pulse pressure variation, <italic>CVVH</italic>: continuous veno-venous hemofiltration, <italic>IAP</italic>: intra-abdominal pressure, <italic>MAP</italic>: mean arterial pressure, <italic>PPV</italic>: pulse pressure variation, <italic>RRT</italic>: renal replacement therapy, <italic>SVV</italic>: stroke volume variation, <italic>UF</italic>: ultrafiltration, <italic>BIA</italic>: bio-electrical impedance analysis</p></table-wrap-foot></table-wrap><table-wrap id="Tab2"><label>Table&#x000a0;2</label><caption><p>Terminology</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left">Resuscitation fluids</td><td align="left">Resuscitation fluids refer to the fluids administrated in the early initial phase of shock to restore of adequate organ perfusion. They should only be given in case of shock (DO<sub>2</sub>/VO<sub>2</sub> imbalance with increased lactate) AND low preload AND fluid responsiveness and they should always be given as a fluid challenge i.e. assessing fluid status and fluid responsiveness before and after. Most often they are given as a bolus of 4ml/kg over 10&#x02013;15 min [<xref ref-type="bibr" rid="CR5">5</xref>]</td></tr><tr><td align="left">Fluid Creep</td><td align="left">A term that refers to the unintentional and unmeasured fluid volumes administered in the process of delivering other medication (antibiotics, sedatives, painkillers, etc.) and/or nutrition through enteral and parenteral routes</td></tr><tr><td align="left">Maintenance fluids</td><td align="left">Maintenance fluids are a source of water, electrolytes and also potentially glucose. The aim of maintenance fluid is to cover the daily needs and prevent dehydration and electrolyte disorders, if the patients need is not met through other sources (i.e. nutrition)</td></tr><tr><td align="left">De-escalation</td><td align="left">Refers to not initiating extra fluids (withhold) or lowering of the dose or speed of administration (withdraw/reduction) of previously started fluid therapy due to improvement in the clinical condition of the patient</td></tr><tr><td align="left">De-resuscitation</td><td align="left">Correction of fluid accumulation or fluid overload by active removal of the excess fluids using non-pharmacological mechanical (e.g., dialysis with net ultrafiltration) or pharmacological (e.g., diuretics) methods</td></tr></tbody></table><table-wrap-foot><p>Fluid creep may sum up to 33% of all fluids administered, compared to maintenance/replacement (25%), nutrition (33%) and resuscitation (6%) [<xref ref-type="bibr" rid="CR6">6</xref>]</p></table-wrap-foot></table-wrap><table-wrap id="Tab3"><label>Table 3</label><caption><p>Treatment (de-resuscitation) of fluid accumulation syndrome (FAS)</p></caption><graphic position="anchor" xlink:href="13613_2024_1403_Tab3_HTML" id="MO1"/><table-wrap-foot><p>Table adapted with permission from Malbrain et al. according to the Open Access CC BY Licence 4.0 (ESM file) [<xref ref-type="bibr" rid="CR1">1</xref>]</p><p>This table presents some suggestions for prevention and treatment of fluid accumulation based on personal experience of the co-authors. It does not aim to provide an exhaustive, graded and concise overview of the literature as current evidence is mostly limited to observational, retrospective or small clinical studies, and more randomized trials are needed to better establish a personalized approach to fluid management. For more information we refer the reader to some recent review papers on this topic (11, 12).</p><p><italic>EN</italic>: enteral nutrition, <italic>EVLWI</italic>: extra-vascular lung water index, <italic>FA</italic>: fluid accumulation, <italic>APP</italic>: abdominal perfusion pressure (MAP minus IAP), <italic>IAP</italic>: intra-abdominal pressure, <italic>PEEP</italic>: positive end-expiratory pressure, <italic>PF</italic>: P<sub>a</sub>O<sub>2</sub> over F<sub>i</sub>O<sub>2</sub> ratio, <italic>PPV</italic>: pulse pressure variation, <italic>CVVH</italic>: continuous veno-venous hemofiltration, <italic>IAP</italic>: intra-abdominal pressure, <italic>MAP</italic>: mean arterial pressure, <italic>PPV</italic>: pulse pressure variation, <italic>RRT</italic>: renal replacement therapy, <italic>SVV</italic>: stroke volume variation, <italic>UF</italic>: ultrafiltration, <italic>BIA</italic>: bio-electrical impedance analysis</p><p>*Target net ultrafiltration needs to be tailored to the individual patient and adjusted based on the haemodynamics and fluid requirements of the patient. It may need to be slower in patients with cardiogenic shock and higher in patients who are very fluid overloaded and also have large fluid requirements, ie blood products, TPN etc.</p></table-wrap-foot></table-wrap></p><p id="Par3">The authors identified an error in Figs. 1, 2 and 3. Figure 1 has now been replaced by a Textbox 1 on the critical appraisal of the definition for fluid accumulation syndrome. Figure 2 then became Figure <xref rid="Fig1" ref-type="fig">1</xref> and Figure 3 became a modified Figure <xref rid="Fig2" ref-type="fig">2</xref>. The corrected figures are given below as well as the textbox. <fig position="anchor" id="Figa"><label>Textbox&#x000a0;1</label><caption><p>Critical appraisal of fluid accumulation syndrome (FAS)</p></caption><graphic position="anchor" xlink:href="13613_2024_1403_Figa_HTML" id="MO01"/></fig><fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>Potential adverse consequences of fluid accumulation. Adapted with permission from Malbrain et al. according to the Open Access CC BY Licence 4.0 [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. Effects mentioned are related to the setting of sepsis, capillary leak and fluid accumulation. I.e. the numbness refers to the presence of peripheral edema and anasarca that may cause skin conduction disturbances, compression of nerves, reduced blood flow and reduced mobility. Additionally, severe and prolonged fluid imbalances can lead to a range of health issues and complications, including electrolyte imbalances, which may indirectly affect the body's ability to respond to stress, including the production of cortisol by the adrenal glands. <italic>APP</italic> abdominal perfusion pressure (MAP minus IAP), <italic>RSB</italic> rapid shallow breathing, <italic>HCS</italic> hepatic congestion, <italic>GRV</italic> gastro-esophageal reflux, <italic>CARS</italic> cardiac-renal syndrome, <italic>AKI</italic> acute kidney injury, <italic>JVP</italic> jugular venous pressure, <italic>HJR</italic> hepato-jugular reflux</p></caption><graphic xlink:href="13613_2024_1403_Fig1_HTML" id="MO2"/></fig><fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>The 4 phases conceptual ROSE model and deleterious effects of fluid accumulation syndrome<bold>.</bold> Adapted with permission from Malbrain et al. according to the Open Access CC BY Licence 4.0 [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. <italic>IAP:</italic> intra-abdominal pressure<italic>, BIA:</italic> bio-impedance analysis, <italic>COP</italic>&#x000a0;colloid oncotic pressure, <italic>ECW/ICW</italic>&#x000a0;extracellular/intracellular water,&#x000a0;<italic>EGDT</italic> early goal directed therapy, <italic>EVLWI</italic>&#x000a0;extra-vascular lung water index, <italic>FAS</italic> fluid accumulation syndrome<italic>, FB</italic> fluid balance<italic>, GEDVI</italic>&#x000a0;global end-diastolic volume index, <italic>IVCCI</italic>&#x000a0;inferior vena cava collapsibility index,&#x000a0;<italic>LVEDAI</italic>&#x000a0;left ventricular end-diastolic area index,&#x000a0;<italic>MAP</italic>&#x000a0;mean arterial pressure,&#x000a0;<italic>OCS</italic>&#x000a0;ocular compartment syndrome,&#x000a0;<italic>PAOP</italic>&#x000a0;pulmonary artery occlusion pressure, <italic>PLR</italic>&#x000a0;passive leg raising,&#x000a0;<italic>PPV</italic>&#x000a0;pulse pressure variation,&#x000a0;<italic>PVPI</italic>&#x000a0;pulmonary vascular permeability index,&#x000a0;<italic>RVEDVI</italic>&#x000a0;right ventricular end-diastolic volume index,&#x000a0;<italic>RVR</italic>&#x000a0;renal vascular resistance,&#x000a0;<italic>S</italic><sub><italic>cv</italic></sub><italic>O</italic><sub><italic>2</italic></sub>&#x000a0;central venous oxygen saturation,&#x000a0;<italic>S</italic><sub><italic>v</italic></sub><italic>O</italic><sub><italic>2</italic></sub>&#x000a0;mixed venous oxygen saturation,&#x000a0;<italic>SV</italic>&#x000a0;stroke volume,&#x000a0;<italic>SVV</italic>&#x000a0;stroke volume variation.</p><p>Artwork kindly provided by Dr Ricardo Castro, Pontificia Universidad Cat&#x000f3;lica de Chile, Chile</p></caption><graphic xlink:href="13613_2024_1403_Fig2_HTML" id="MO3"/></fig></p><p id="Par4">The original article has been corrected.</p></body><back><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ref-list id="Bib1"><title>Reference</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="other">Finfer S, Bellomo R, McEvoy S, Lo SK, Myburgh J, Neal B, et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. Bmj. 2006;333(7577):1044.</mixed-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="other">Malbrain M, Martin G, Ostermann M. Everything you need to know about deresuscitation. Intensive Care Med. 2022;48(12):1781&#x02013;6.</mixed-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="other">Malbrain M, Van Regenmortel N, Saugel B, De Tavernier B, Van Gaal PJ, Joannes-Boyau O, et al. Principles of fluid management and stewardship in septic shock: it is time to consider the four D&#x02019;s and the four phases of fluid therapy. Ann Intensive Care. 2018;8(1):66.</mixed-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="other">Wiedermann CJ. Phases of fluid management and the roles of human albumin solution in perioperative and critically ill patients. Curr Med Res Opin. 2020;36(12):1961&#x02013;73.</mixed-citation></ref><ref id="CR5"><label>5.</label><mixed-citation publication-type="other">Aya HD, Rhodes A, Chis Ster I, Fletcher N, Grounds RM, Cecconi M. Hemodynamic effect of different doses of fluids for a fluid challenge: a quasi-randomized controlled study. Crit Care Med. 2017;45(2):e161&#x02013;8.</mixed-citation></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="other">Van Regenmortel N, Verbrugghe W, Roelant E, Van den Wyngaert T, Jorens PG. Maintenance fluid therapy and fluid creep impose more significant fluid, sodium, and chloride burdens than resuscitation fluids in critically ill patients: a retrospective study in a tertiary mixed ICU population. Intensive Care Med. 2018;44(4):409&#x02013;17.</mixed-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="other">Malbrain M, Martin G, Ostermann M. Everything you need to know about deresuscitation. Intensive Care Med. 2022;48(12):1781&#x02013;6.</mixed-citation></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="other">Malbrain M, Langer T, Annane D, Gattinoni L, Elbers P, Hahn RG, et al. Intravenous fluid therapy in the perioperative and critical care setting: executive summary of the International Fluid Academy (IFA). Ann Intensive Care. 2020;10(1):64.</mixed-citation></ref></ref-list></back></article>